| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $125K | +0.0% |
| R&D Expense | $24.5M | +17.9% |
| SG&A Expense | $13.9M | -1.2% |
| Operating Income | -$38.4M | -10.6% |
| Interest Expense | $2.6M | +51.9% |
| Income Tax | $0 | — |
| Net Income | -$37.9M | -101.9% |
| EPS (Basic) | -$1.31 | -101.5% |
| EPS (Diluted) | -$1.31 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.4M | -49.5% |
| Current Assets | $36.8M | -48.9% |
| Total Assets | $41.2M | -47.0% |
| Current Liabilities | $14.2M | +152.6% |
| Long-term Debt | $11.6M | — |
| Total Liabilities | $28.5M | -5.1% |
| Stockholders' Equity | $12.7M | -73.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$34.2M | -9.0% |
| Capital Expenditures | $457K | -64.8% |
| Investing Cash Flow | -$280K | +78.4% |
| Financing Cash Flow | -$121K | -100.6% |
| Free Cash Flow | -$34.7M | -6.1% |
| -101.5% |